NIH 'very concerned' about serious side effect in AstraZeneca coronavirus vaccine trial  CNNView Full coverage on Google News

Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.

Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will

Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will

Sentiment is still cautious before a big week of central bank meetings in the UK, Japan and the US.Sentiment is still cautious before a big week of central bank meetings in the UK, Japan and the US.

Asian shares rise as coronavirus vaccine hopes renew | News | Al Jazeera

The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc's U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do "very significant work" with the company as it conducts its investigation after an illness in a participant...The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc's U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do "very significant work" with the company as it conducts its investigation after an illness in a participant...

U.S. FDA's Hahn plans 'significant' work with AstraZeneca in COVID-19 trial inquiry | Reuters

US regulators have not allowed AstraZeneca's vaccine trial to resume in America and first want to determine if the jab or another factor caused a UK participant to suffer spinal cord inflammation.US regulators have not allowed AstraZeneca's vaccine trial to resume in America and first want to determine if the jab or another factor caused a UK participant to suffer spinal cord inflammation.

US regulators are 'very concerned' about the side effects of AstraZeneca's vaccine | Daily Mail Online

While the FDA weighs whether to resume its trial of AstraZeneca's COVID-19 vaccine, which triggered a clinical hold last week after a U.K. patient was hit with a serious side effect, the NIH has launched its own study into the reaction—which could take up to two months to wrap, one NIH officer said.While the FDA weighs whether to resume its trial of AstraZeneca's COVID-19 vaccine, which triggered a clinical hold last week after a U.K. patient was hit with a serious side effect, the NIH has launched its own study into the reaction—which could take up to two months to wrap, one NIH officer said.

NIH 'very concerned' about serious side effect in coronavirus vaccine trial | FiercePharma

Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.

Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare: investigator | Article [AMP] | Reuters

The U.S. NIH has launched an investigation into the case of a patient who suffered spinal cord damage after joining AstraZeneca's coronavirus vaccine trial.The NIH has launched an investigation into the case of a patient who suffered spinal cord damage after joining AstraZeneca's coronavirus vaccine trial.

NIH ‘concerned’ about side effect in coronavirus vaccine trial - Los Angeles Times

403 Forbidden

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.

Biopharma Update on the Novel Coronavirus: September 14 | BioSpace

Johnson & Johnson will kick off Phase 2 trials of its COVID-19 vaccine candidate in Spain on Monday, according to the trial’s unit head Alberto Borobia.The first stage of the Phase 2 trial study of J&J’s (JNJ) vaccine, which will be conducted across three hospitals in Spain, is expected to be concludedJohnson & Johnson will kick off Phase 2 trials of its COVID-19 vaccine candidate in Spain on Monday, according to the trial’s unit head Alberto Borobia.The first stage of the Phase 2 trial study of J&J’s (JNJ) vaccine, which will be conducted across three hospitals in Spain, is expected to be concluded

Johnson & Johnson Kicks Off Phase 2 Covid-19 Vaccine Trial In Spain – Report

The magazine’s Ethicist columnist on whether participating in a vaccine trial means you can act as if you’re part of an “immune elite” — and more.The magazine’s Ethicist columnist on whether participating in a vaccine trial means you can act as if you’re part of an “immune elite” — and more.

Regulators in the United Kingdom allowed the AstraZeneca vaccine trial to resume, but U.S. regulators are continuing to investigate.Regulators in the United Kingdom allowed the AstraZeneca vaccine trial to resume, but U.S. regulators are continuing to investigate.

Feds ‘Very Concerned’ About AstraZeneca COVID-19 Vaccine Side Effect

The COVID-19 pandemic continues to evolve from four fundamental aspects: the health impact and response, the economic and market impact and the policy action from both central banks and governments worldwide.  Global confirmed cases of COVID-19 have now exceeded 29 million. Despite the rise in...The COVID-19 pandemic continues to evolve from four fundamental aspects: the health impact and response, the economic and market impact and the policy action from both central banks and governments worldwide.  Global confirmed cases of COVID-19 have now exceeded 29 million. Despite the rise in...

COVID-19 vaccine – the key growth catalyst

Lessons learned from the CDC's efforts to distribute the H1N1 vaccine can inform a national Covid-19 vaccine distribution strategy.Lessons learned from the CDC's efforts to distribute the H1N1 vaccine can inform a national Covid-19 vaccine distribution strategy.

The key to efficient vaccine distribution: start preparing early - STAT

Some 170 Covid-19 vaccines are in development around the world, according to the World Health Organization. Now, a handful are starting the final stage of testing.

Covid-19 Vaccines: What's Coming and When?

Error 406 - Not Acceptable

“Many have called to ask us some more detail about the risk of the vaccine, whether what happened with that vaccine had anything to do with the one we are studying."“Many have called to ask us some more detail about the risk of the vaccine, whether what happened with that vaccine had anything to do with the one we are studying."

Volunteers quit coronavirus trial in Spain amid concerns - New York Daily News

The vaccine to be tested was developed by US corporation Johnson & Johnson.The trials in Spain will fall under Phase 2, to be also held in Germany and Belgium.The vaccine to be tested was developed by US corporation Johnson & Johnson.The trials in Spain will fall under Phase 2, to be also held in Germany and Belgium.

Spain to begin clinical trials of Johnson & Johnson Covid-19 vaccine today

European markets opened broadly higher and US futures rally more than 1%European markets opened broadly higher and US futures rally more than 1%

Central bank meetings dampen global stock boost on coronavirus vaccine hopes

The Bank of Japan and the Bank of England will announce their respective policy decisions on ThursdayThe Bank of Japan and the Bank of England will announce their respective policy decisions on Thursday

Asian shares on firm footing as vaccine trials resume | Dhaka Tribune

Beside the Russian vaccine, according to WHO database, there are at least 34 more vaccine candidates in various phases of clinical trials.Beside the Russian vaccine, according to WHO database, there are at least 34 more vaccine candidates in various phases of clinical trials.

As Big Pharma Players Race Against Time for Covid-19 Vaccine, Here's When it May Actually Reach Us

Experts call the global response to the COVID-19 pandemic a "collective failure."Experts call the global response to the COVID-19 pandemic a "collective failure."

Pandemic total passes 29 million as cases hit daily high | CIDRAP

Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines.Here are the answers to your top questions about where things stand with the development of COVID-19 vaccines.

Coronavirus Vaccine Race: 7 Key Things You'll Want to Know | The Motley Fool

There is a growing outcry among independent scientists and public health experts, who say drug companies need to be more open about how vaccine trials are run.There is a growing outcry among independent scientists and public health experts, who say drug companies need to be more open about how vaccine trials are run.

Coronavirus vaccine-makers keep safety details quiet, alarming scientists - Chicago Tribune

US President Donald Trump has hinted a Covid-19 vaccine may be ready before the November election, but will it be safe and effective? Experts are worried the country’s world-renowned health institutions responsible for overseeing the approval and distribution processes have become increasingly compromised by political pressure, which could end up costing lives. The Food and […]

‘Unprecedented’: Experts slam White House pressure on US health agencies – Raw Story

(Reuters) - The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc's U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do "very significant work" with the company as it conducts its investigation after an illness in a participant in Britain.(Reuters) - The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc's U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do "very significant work" with the company as it conducts its investigation after an illness in a participant in Britain.

U.S. FDA's Hahn plans 'significant' work with AstraZeneca in COVID-19 trial inquiry | The Star

Gold was firm, with spot prices at $1,949.7 per ounce.Gold was firm, with spot prices at $1,949.7 per ounce.

Asian shares buoyed by coronavirus vaccine hopes - News | Khaleej Times

Regulators in the United Kingdom allowed the AstraZeneca vaccine trial to resume, but U.S. regulators continue to investigate.Regulators in the United Kingdom allowed the AstraZeneca vaccine trial to resume, but U.S. regulators continue to investigate.

NIH and FDA Examine Serious Side Effect That Surfaced in COVID Vaccine Trial - WebMD

403 Forbidden

AstraZeneca's COVID-19 vaccine trials were placed on hold worldwide on Sept. 6 after a serious side effect was reported in one volunteer in Britain.AstraZeneca's COVID-19 vaccine trials were placed on hold worldwide on Sept. 6 after a serious side effect was reported in one volunteer in Britain.

Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare - investigator - The Peninsula Qatar

Some volunteers have quit Johnson & Johnson's COVID19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.Some volunteers have quit Johnson & Johnson's COVID19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.

Some Volunteers Quit J&J COVID-19 Trial In Spain After AstraZeneca Scare: Investigator

Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain.Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain.

Coronavirus: Johnson & Johnson COVID-19 vaccine trial patients quit after problems with AstraZeneca's | Newshub

SYDNEY (REUTERS) - Asian shares firmed on Monday (Sept 14) on renewed hopes for a coronavirus vaccine after AstraZeneca resumed its phase-3 trial though sentiment was still cautious ahead of a big week of central bank meetings in UK, Japan and the United States.. Read more at straitstimes.com.Companies & Markets News -SYDNEY (REUTERS) - Asian shares firmed on Monday (Sept 14) on renewed hopes for a coronavirus vaccine after AstraZeneca resumed its phase-3 trial though sentiment was still

Asia shares buoyed by coronavirus vaccine hopes, Companies & Markets News & Top Stories - The Straits Times